Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, net loss was USD 2.87 million compared to USD 1.72 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0033 USD | -10.81% | 0.00% | -8.33% |
1st Jan change | Capi. | |
---|---|---|
-8.33% | 5.12M | |
+3.25% | 108B | |
+11.16% | 104B | |
+1.28% | 22.33B | |
-12.78% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.62% | 17.64B | |
+4.29% | 14.05B | |
+34.84% | 12.51B |